Andy Trotti

The University of Texas MD Anderson Cancer Center

Papers

Total Citations

123

H-Index

About

Andy Trotti is a leading figure in radiation oncology, whose work has fundamentally shaped the treatment of head and neck cancers, particularly through the lens of organ preservation. His research centers on optimizing therapeutic strategies to balance cancer control with quality of life, a challenge he has tackled through rigorous clinical investigation. A cornerstone of his contribution is the landmark review "Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes" (2015, 123 citations), which critically analyzes the pivotal trials and ongoing controversies surrounding larynx-sparing approaches. This work, alongside his extensive portfolio, has helped define the evidence-based framework for selecting patients for non-surgical management, moving the field beyond simple survival metrics to consider functional outcomes. Trotti’s impact is further underscored by his leadership in developing and validating standardized toxicity criteria (CTCAE), a tool used globally to systematically report treatment side effects. With thousands of citations across his body of work, his influence is evident in both the design of modern clinical trials and the daily decisions made in multidisciplinary tumor boards, cementing his legacy as a clinician-scientist dedicated to improving both the quantity and quality of life for cancer patients.